AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Joel D Levin

Examiner Joel D Levin appears to be about average relative to their peer examiners. Their lifetime grant ratio is 19.6%, they average 2.11 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC Very Hard
Difficulty vs USPTO Very Hard
Average OA / Grant 2.11
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
4 years (2023-2026)
Phone
(571) 270-0616
Predicted Supervisor
Christopher Babic
Supervisor Phone
(571) 272-8507
Tech Center
1600 - Biotechnology and Organic
Group
1630 - Stem Cells and Nucleic Acid Related Therapy

Metrics

Applications Evaluated
97
Granted Applications
19
Non-Granted Applications
78
Avg OA / Grant
2.11
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1633
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 19.6% 2.11
Art Unit 31 38.9% 2.18
Group 243 38.4% 2.18
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2023; examiner may not yet have been active in the available dataset.
2023 1 0 0.0%
2024 25 10 40.0%
2025 57 9 15.8%
2026 14 0 0.0%

19 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 94 1.1% 8.5% 74.5% 6.4%
2 65 4.6% 15.4% 70.8% 4.6%
3 28 7.1% 17.9% 60.7% 10.7%
4 9 0.0% 11.1% 66.7% 11.1%
5 4 0.0% 25.0% 75.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2023
2.1%
2024
4.8%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.